Bolt Biotherapeutics GAAP EPS of -$0.29, revenue of $1.2M
Source: SeekingAlpha
2025-05-13 08:57:30 ET
More on Bolt Biotherapeutics
- Seeking Alpha’s Quant Rating on Bolt Biotherapeutics
- Historical earnings data for Bolt Biotherapeutics
- Financial information for Bolt Biotherapeutics
Read the full article on Seeking Alpha
For further details see:
Bolt Biotherapeutics GAAP EPS of -$0.29, revenue of $1.2M
Bolt Biotherapeutics Inc.
NASDAQ: BOLT
BOLT Trading
-3.8% G/L:
$4.30 Last:
15,092 Volume:
$4.66 Open:
BOLT Latest News
March 12, 2026 04:05:00 pm
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
November 12, 2025 04:05:00 pm
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
BOLT Stock Data
$9,654,980
1,435,742
5.47%
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
